<DOC>
	<DOCNO>NCT00004895</DOCNO>
	<brief_summary>RATIONALE : Palliative therapy octreotide may help patient bowel obstruction remove surgery live longer comfortably . PURPOSE : Phase II trial study effectiveness octreotide palliative therapy treat patient cancer-related bowel obstruction remove surgery .</brief_summary>
	<brief_title>Octreotide Palliative Therapy Cancer-Related Bowel Obstruction That Can Be Removed Surgery</brief_title>
	<detailed_description>OBJECTIVES : - Determine effectiveness octreotide palliation bowel obstruction secondary cancer . - Characterize dose tolerability octreotide patient population . OUTLINE : Patients receive octreotide subcutaneously IV 24 hour day 2-5 . Patients respond well study may continue octreotide palliative effect . PROJECTED ACCRUAL : A total 9-25 patient accrue study 9 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<mesh_term>Intestinal Neoplasms</mesh_term>
	<mesh_term>Intestinal Obstruction</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Inoperable bowel obstruction secondary cancer OR Metastatic primary abdominal cancer Patient present vomit Percutaneous gastrostomy tube allow PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 04 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No documented hypersensitivity octreotide Not pregnant nursing PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Prior chemotherapy allow Endocrine therapy : Concurrent steroid allow Radiotherapy : Prior radiotherapy allow Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage I gastric cancer</keyword>
	<keyword>stage II gastric cancer</keyword>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>recurrent gastric cancer</keyword>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage I ovarian epithelial cancer</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>small intestine adenocarcinoma</keyword>
	<keyword>small intestine lymphoma</keyword>
	<keyword>small intestine leiomyosarcoma</keyword>
	<keyword>localize extrahepatic bile duct cancer</keyword>
	<keyword>unresectable extrahepatic bile duct cancer</keyword>
	<keyword>recurrent extrahepatic bile duct cancer</keyword>
	<keyword>recurrent small intestine cancer</keyword>
	<keyword>constipation , impaction , bowel obstruction</keyword>
	<keyword>peritoneal cavity cancer</keyword>
	<keyword>nausea vomit</keyword>
	<keyword>gastrointestinal stromal tumor</keyword>
</DOC>